B cells are susceptible to Fas ligand (FasL) ϩ CD4 ϩ Th1 cell-mediated apoptosis. We demonstrate that blocking the interactions between lymphocyte function associated (LFA)-1 and intercellular adhesion molecule(ICAM)-1 and ICAM-2 completely suppresses Fas-dependent B cell lysis. Antibodies to CD2 and CD48 partially suppress B cell apoptosis, whereas anti-B7.1 and anti-B7.2 antibodies have no effect. Also, B cells from ICAM-1-deficient mice are resistant to FasL ϩ T cell-mediated death. Our results suggest that LFA-1/ICAM interactions are crucial for Th1 cell-mediated B cell apoptosis and may contribute to the maintenance of B cell homeostasis in vivo.
B cells are sensitive to apoptosis mediated by Fas (Apo-1/CD95; references [1] [2] [3] [4] . The importance of Fas in B cell apoptosis is supported by B cell accumulation and autoantibody production in mice with defective Fas or Fas ligand (FasL) genes or in humans with mutated Fas genes (5) (6) (7) (8) . Although Fas-FasL interactions are important for T cell apoptosis after TCR cross-linking, B cell apoptosis induced by cross-linking of the B cell antigen receptor does not involve Fas (9) , suggesting that B and T cells differ in Fas-dependent apoptosis. Since FasL expression is undetectable in a variety of mouse and human B cell lines (9, 10) , B cells are likely to depend on apoptotic signals through Fas that are generated by interactions with FasLbearing T cells (11, 12) .
Fas-mediated signaling in B cells appears to be regulated by the cell activation status. While resting B cells resist Fas cross-linking-induced death, mitogen-activated B cells are susceptible to Fas-mediated killing (13) . Cross-linking of CD40 leads to upregulation of Fas expression and sensitivity to Fas-mediated apoptosis (14, 15) . The roles of adhesion molecules or accessory molecules have not been characterized in CD4 ϩ T cell-mediated B cell lysis by the Fas pathway (16) . We examined the roles of accessory molecules in Fasmediated B cell lysis. We found that the interactions of LFA-1 on CD4 ϩ T cells and intercellular adhesion molecule-1 and ICAM-2 on B cells are essential for the T cellmediated B cell lysis. Deficiency in ICAM-1 leads to decreased B cell apoptosis and the accumulation of B cells in vivo.
Materials and Methods
Mice. 6-8-wk-old female C57BL/6, C57BL/6-ICAM-1 Ϫ / Ϫ , B10.A, and BALB/c mice were obtained from the Jackson Laboratory (Bar Harbor, ME).
Antibodies, Fusion Proteins, and Peptides
anti-Fas (Jo2), anti-CD4 (GK1.5), anti-CD8 (53-6.7), anti-Thy-1.2 (30-H12), anti-NK1.1 (PK136), anti-CD40 (3/12), antiFasL, anti-CD16/32, PE conjugated anti-Fas, PE-conjugated anti-ICAM-1, PE-conjugated anti-ICAM-2, FITC-conjugated anti-LFA-1, FITC-or PE-conjugated anti-CD4, and PE-conjugated anti-CD3 were purchased from PharMingen (San Diego, CA). FITC-conjugated F(ab Ј ) 2 goat anti-mouse IgM was obtained from CALTAG (South San Francisco, CA). Fas-Fc and TNFR-Fc fusion proteins were gifts from Dr. D. Lynch (Immunex, Seattle, WA). The pigeon cytochrome C peptide (amino acid residues 88-104: KAERADLIAYLKQATAK) was synthesized by the Peptide Synthesis Facility (National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD).
Purification and Stimulation of B Cells. Mouse spleen cells were suspended in RPMI 1640 medium containing 20% FCS (5 ϫ 10 6 cells/ml) and 10 ml cells were added to each 100 mm tissue culture dish. After incubation at 37 Њ C for 1 h, nonadherent cells were recovered and resuspended in HBSS medium (10 7 /ml) containing 10 g/ml of anti-Thy-1.2, anti-CD4, anti-CD8, and anti-NK1.1 antibodies, and then incubated on ice for 45 min. Next, 1:10 low-tox-M rabbit complement (Accurate Chemical and Science Corp., Westbury, NY) was added and the cells were incubated at 37 Њ C for 1 h. Live cells were purified by Ficoll gradient separation and between 95 and 98% of the cells were positive for surface IgM when stained with a PE-conjugated F(ab Ј ) 2 goat anti-mouse IgM (data not shown). The cells (10 6 cells/ml) were resuspended in RPMI 1640 medium with 10% FCS, 0.2 mM glutamine, 5 ϫ 10 Ϫ 4 M ␤ -mercaptoethanol (RPMI complete medium) containing 100 g/ml LPS, or 5 g/ml anti-CD40 and cultured at 37 Њ C for 2 or 3 d before use.
Stimulation of T Cells and 51 Cr-release Assay. A.E7 T cells were stimulated with antigen and IL-2 as previously described (17) . To induce allo-specific CD4 ϩ T cells, BALB/c spleen cells were suspended in RPMI complete medium containing 1 g/ml FITC conjugated anti-CD4 (10 7 cells/ml) and incubated on ice for 30 min. CD4 ϩ cells were then purified with magnetic beads conjugated with sheep antifluorescein antibody (PerSeptive Diagnostics, Cambridge, MA). The CD4 ϩ T cells were mixed with 3,000 Rad-irradiated C57BL/6 mouse spleen cells at a ratio of ‫ف‬ 1:5 and suspended in RPMI complete medium (10 6 CD4 ϩ T cells/ ml). After culture at 37 Њ C for 5 d, live cells were purified and used as effector cells to assay B cell lysis. For 51 Cr-release assay, B cells were incubated in RPMI medium containing 5% FCS (5 ϫ 10 6 /ml) and 200 Ci/ml Na[ 51 Cr]O 4 (New England Nuclear, Boston, MA) with or without 10 m antigenic peptide at 37 Њ C for 1 h followed by washing with HBSS three times. The labeled B cells (10 4 /well) were incubated with T cells in a total volume of 200 l in RPMI complete medium at various ratios in triplicates in 96-well U-bottomed plates (Nunc, Roskilde, Denmark). Various antibodies, isotype-matched antibody controls, Fas-Fc, or TNFR-Fc fusion proteins at 10 g/ml were added as indicated. After 4 h incubation at 37 Њ C, percentage cell loss was quantitated as described (2) .
Induction of B Cell Apoptosis with Anti-Fas. B cells were suspended in RPMI complete medium (0.5 ϫ 10 6 cells/ml) containing 1 g/ml of Jo2 (anti-Fas) or control hamster IgG. The cells (10 5 /well) were cultured in 96-well flat-bottomed plates at 37 Њ C for 24 h. Viable cells were quantitated and percentage of cell loss was calculated as described previously (6) .
Staining of Cell Surface Markers. AE.7 cells were cultured in RPMI complete medium (10 6 /ml) with or without 3,000 Radirradiated B10A spleen cells (5 ϫ 10 6 /ml) and 10 M pigeon cytochrome C peptide 88-104. A metalloproteinase inhibitor, KBR8301 (18) , was added to 10 g/ml and the cells were cultured at 37 Њ C for 6 h. The cells were then stained with PE-conjugated anti-FasL and FITC-conjugated anti-CD4 followed by flow cytometry. CD4 ϩ AE7 cells were gated to analyze FasL expression. To examine the expression of accessory molecules, B cells were blocked by incubating with 10 g/ml anti-CD16/32, 1:100 normal rat serum, and 10 g/ml normal hamster IgG on ice for 30 min. The cells were next stained with 1 g/ml PEconjugated anti-Fas, FITC-conjugated anti-LFA-1, PE-conjugated anti-ICAM-1, or PE-conjugated anti-ICAM-2. Isotype-matched FITC-or PE-conjugated rat anti-CD4 or PE-conjugated hamster anti-CD3 were used as negative controls. After incubation on ice for 30 min, the cells were analyzed by flow cytometry.
Results and Discussion
Fas-dependent and Antigen-specific Lysis of B Cells by CD4 ϩ T Cells. We first tested the lysis of B cells by T cells in a Th1-mediated cytotoxicity assay. We used either A.E7, a CD4 ϩ Th1 clone that recognizes pigeon cytochrome C amino acids 88-104 presented by I-E k (19) , or allo-reactive CD4 ϩ T cells generated from an MLR. Resting B cells or B cell blasts from either B10.A mice (I-E k ϩ ) pulsed with the pigeon cytochrome C peptide or B cells from C57BL/ 6 mice were targets for A.E7 and the allo-reactive T cells, respectively. We found that A.E7 cells efficiently lyse B cell targets preactivated with either LPS or anti-CD40 but not untreated resting B cells (Fig. 1 A ) . Blocking of Fas-FasL interactions by Fas-Fc abolished the lysis of B cell targets by A.E7 cells (Fig. 1 B ) , whereas TNFR-Fc, a blocker for TNF action, did not interfere with B cell death (Fig. 1 B ) . Similar results were obtained with allo-reactive CD4 ϩ T cells (Fig. 1, C and D ) . These data agree with previous findings that lysis of target B cells by CD4 ϩ T cells is predominantly Fas dependent (2) . Antigen-specific recognition by T cells is required because A.E7 cells failed to lyse target B cells that were not pulsed with antigen before the assay (reference 1 and data not shown). Thus, Th1-mediated cytotoxicity against B cells is Fas and antigen dependent.
Involvement of Accessory Molecules in Th1-mediated Lysis of
B Cells. We next tested mAbs to block accessory molecules in the T cell-mediated, B cell cytotoxicity assays. We found that anti-LFA-1 completely blocked the killing of target B cells by A.E7 (Fig. 2 A ) . Similar results were observed with allo-reactive T cells. B cell lysis was also significantly suppressed by anti-ICAM-1 but not by anti-ICAM-2 alone (Fig. 2, A and B ) . Both anti-ICAM-1 and anti-ICAM-2 together nearly completely suppressed B cell apoptosis. Therefore, both ICAM-1 and ICAM-2 are involved in T cell-mediated B cell killing, but ICAM-1 appears to be more important.
In contrast, blocking mAbs to B7.1 and B7.2 had no effect on B cell lysis by CD4 ϩ T cells (Fig. 2, A and B ) , although CD28 and B7 molecules are highly expressed on the T and B cells used in these assays (data not shown). This indicates that the CD28/B7 interaction is not involved in CD4 ϩ T cell-mediated B cell killing. These results also suggest that the blocking of B cell lysis by other antibodies is not simply a steric effect due to antibodies bound to cell surface structures. We also examined CD2 on T cells and CD48 on B cells, another receptor-ligand pair important for T-B cell interactions in mice (20) . We found that B cell lysis was inhibited by anti-CD2 and anti-CD48 (Fig. 2, A and B ) , but the effect was much weaker than by blocking of LFA-1-ICAM interactions.
Our results suggested that their physical interaction, possibly by promoting Th1-B cell adhesion, was involved in Th1-mediated B cell apoptosis. However, an alternative possibility is that those mAbs may deliver a negative signal into the cells and inhibit the killing process. We therefore examined whether these mAbs influenced anti-Fas antibody-mediated B cell apoptosis. We first established conditions in which anti-Fas antibody efficiently lysed the B cells (Fig. 2 C ) . We then added anti-LFA-1, anti-ICAM-1, anti-ICAM-2, anti-B7.1, anti-B7.2, anti-CD2, and anti-CD48 and found that none of these affected direct antiFas-mediated B cell lysis. Thus, these mAbs do not interfere with apoptotic signaling from Fas.
It remained possible that LFA-1-ICAM interactions in our assay simply promoted T cell activation and FasL expression rather than facilitate Fas-FasL interactions leading to death. To distinguish between these possibilities, we studied freshly activated A.E7 cells that express more FasL to see if the requirement for LFA-1-ICAM interactions was less. However, anti-LFA-1 and anti-ICAM-1 still blocked B cell lysis by freshly activated A.E7 cells (Fig. 3) . Flow cytometry showed that FasL was upregulated on AE.7 cells immediately after antigen stimulation (Fig. 3) . This supports the hypothesis that LFA-1 and ICAM function primarily to promote T-B cell adhesion for Fas-mediated B cell apoptosis. Although anti-Fas antibodies induce rapid formation of a death-inducing signaling complex linked to the cytoplasmic portion of Fas, proteolytic processing and activation of FLICE/caspase 8 requires up to 20 min of continuous Fas cross-linking (21) . This suggests that the activation of caspases essential for apoptosis requires certain period of stabilized engagement of Fas receptor. It is there- Since the interactions of LFA-1 and ICAM-1 and ICAM-2 are important for the lysis of B cells in vitro, we asked whether they contribute to B cell homeostasis in vivo. We found no abnormality in the B cell compartment in relatively young ICAM-1 Ϫ/Ϫ mice (references 24 and 25 and data not shown), but a 30% increase in IgM ϩ B cells was consistently observed in the spleens of ICAM-1 Ϫ/Ϫ mice at 6 mo of age as compared with wild type mice (data not shown). This suggests that B cells accumulate in these mice with aging. This could be analogous to lpr mice which gradually develop abnormal B cell accumulation and autoimmunity depending on the background of the mouse strain (26) . Although difficult to verify experimentally, our result is consistent with the hypothesis that ICAM-1 is important for B cell apoptosis mediated by T cells in vivo. However, no significant production of autoantibodies has yet been observed in older ICAM-1 Ϫ/Ϫ mice (data not shown). This could be because autoreactive T cells have not accumulated in these mice since T cell apoptosis is not affected by ICAM-1 deficiency (data not shown). An alternative explanation is that the ICAM-1 Ϫ/Ϫ mice used here are on C57BL/6 background which is not prone to autoimmunity. ICAM-1 deficiency on autoimmune mouse backgrounds, such as the MRL strain, might be more appropriate to address such questions. 
